Subsequently, the PI3K/AKT/mTOR was identified as a downstream effector of the has‐circ‐0008234/miR‐338‐3p/ETS1 axis, contributing to enhanced tumor aggressiveness. The gene discussed is PIK3CA; the disease is neoplasm.